
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Fisher & Paykel Healthcare (FPH) is a designer and manufacturer of medical device products used to treat respiratory illness and sleep apnea. Headquartered in New Zealand, it also operates through North America, Europe, and the Asia-Pacific.
FPH is a dividend Health Technology sector stock that is listed on the ASX and holds a position on the S&P/ASX200 index of Australia's 200 largest companies by market capitalisation. Since the 2020 COVID-19 pandemic, there has been heightened interest in Fisher & Paykel Healthcare stocks because of the expected increase in demand for its products.
Technical analysis is used in finance to forecast the direction of prices by studying the past movements of markets. This is not a recommendation, it represents an analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Taking a deep dive into how costly it could be to put all your eggs in one basket.
What you need to know about starting a fridge repair business in Australia.
Here are the key things you'll need to know before your cheese company is ready to start operating.
Here is the essential info you need to know about investing in the stock market for your children.
Want to save up to 40% off at Jeffree Star Cosmetics? This is everything you need to know.
Everything you need to know about the cost of trauma insurance.
Intellectual property agreements protect your business when buying, selling or transferring IP. Here’s what you need to know about these agreements and where to find templates.
Everything you need to know about this highly anticipated Chinese IPO.
This is the final week of our 4-week financial fitness challenge, where we help you understand your savings, super and investments.
The online retailer is expected to raise $40 million as it launches onto the ASX. Here's what you need to know.